摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-氯-4-氟苯基异硫氰酸酯 | 137724-66-4

中文名称
3-氯-4-氟苯基异硫氰酸酯
中文别名
3-氯-4-氟异硫氰酸苯酯;3-氯-4-氟苯硫代异氰酸酯
英文名称
3-chloro-4-fluorophenyl isothiocyanate
英文别名
2-chloro-1-fluoro-4-isothiocyanatobenzene
3-氯-4-氟苯基异硫氰酸酯化学式
CAS
137724-66-4
化学式
C7H3ClFNS
mdl
MFCD00060700
分子量
187.625
InChiKey
BUVRIIKIGKFOKD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    115-117 °C (11 mmHg)
  • 密度:
    1.31±0.1 g/cm3(Predicted)
  • 闪点:
    130-132°C/15mm
  • 稳定性/保质期:
    如果按照规格使用和储存,则不会分解,没有已知的危险反应。应避免与氧化物、水分等接触。

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    11
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    44.4
  • 氢给体数:
    0
  • 氢受体数:
    3

安全信息

  • 危险等级:
    6.1
  • 危险品标志:
    T,C
  • 安全说明:
    S28A,S36/37/39,S45
  • 危险类别码:
    R23/24/25
  • 海关编码:
    2930909090
  • 危险品运输编号:
    2810
  • 包装等级:
    III
  • 危险类别:
    6.1
  • 储存条件:
    请将贮藏器保持密封,并存放在阴凉、干燥处。同时,确保工作环境有良好的通风或排气设施。

SDS

SDS:b3e661ee09ff101c118ba129dc949622
查看
Name: 3-Chloro-4-fluorophenylisothiocyanate Material Safety Data Sheet
Synonym:
CAS: 137724-66-4
Section 1 - Chemical Product MSDS Name:3-Chloro-4-fluorophenylisothiocyanate Material Safety Data Sheet
Synonym:

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
137724-66-4 3-Chloro-4-fluorophenylisothiocyanate 100 unlisted
Hazard Symbols: T
Risk Phrases: 23/24/25

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Toxic by inhalation, in contact with skin and if swallowed.
Potential Health Effects
Eye:
May cause eye irritation. Lachrymator (substance which increases the flow of tears).
Skin:
May cause skin irritation. Toxic in contact with skin.
Ingestion:
May cause irritation of the digestive tract. Poison by ingestion.
Inhalation:
May cause respiratory tract irritation. Toxic if inhaled.
Chronic:
Not available.

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately.
Skin:
Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid immediately. Wash mouth out with water.
Inhalation:
Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
Notes to Physician:

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

Section 7 - HANDLING and STORAGE
Handling:
Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Use only in a chemical fume hood.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 137724-66-4: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: Not available.
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 115 - 117 deg C @ 11 mmHg
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H3ClFNS
Molecular Weight: 187.62

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong bases, acids, water, alcohols, amines.
Hazardous Decomposition Products:
Hydrogen chloride, hydrogen cyanide, sulfur dioxide, carbon monoxide, oxides of nitrogen, carbon dioxide, hydrogen fluoride gas, sulfuric acid, nitric acid.
Hazardous Polymerization: Has not been reported

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 137724-66-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-Chloro-4-fluorophenylisothiocyanate - Not listed by ACGIH, IARC, or NTP.

Section 12 - ECOLOGICAL INFORMATION
Other No information available.

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2810
Packing Group: II
IMO
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing Group: II
RID/ADR
Not regulated as a hazardous material.

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T
Risk Phrases:
R 23/24/25 Toxic by inhalation, in contact with skin
and if swallowed.
Safety Phrases:
S 28A After contact with skin, wash immediately with
plenty of water.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 137724-66-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 137724-66-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 137724-66-4 is not listed on the TSCA inventory.
It is for research and development use only.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3-氯-4-氟苯基异硫氰酸酯mercury(II) oxide 作用下, 以 乙醚乙酸乙酯丙酮 为溶剂, 反应 24.0h, 生成 [2-(3-chloro-4-fluoroanilino)-4-(hydroxymethyl)-5H-1,3-oxazol-4-yl]methanol
    参考文献:
    名称:
    Syntheses, structures and bioactivities of fluorine-containing phenylimino-thia(oxa)zolidine derivatives as agricultural bioregulators
    摘要:
    From insight into the structure of trehazolin as trehalase inhibitor, six series of fluorine-containing phenylimino-thiazolidines (oxazolidines) derivatives were designed and prepared through a convenient synthesis of fluoroaryl isothiocyanate and a one-pot facile synthesis in high yield of fluorophenyl aminobenzoxazoles by cyclodesulfurization. The structures of the target compounds were confirmed with using IR, NMR, MS and elemental analysis. Their X-ray crystal analysis suggested that there were novel intermolecular (sp(2)CF(...)H(3)C-) and intramolecular (sp(2)CF(...)HN) hydrogen bonds between the fluorine atom on benzene ring and hydrogen atom of methyl group or amino group on five-membered heterocycle. Their fungicidal activities against Rhizoctonia solani and Pyricuraria oryzae at 100 ppm were determined. (C) 2004 Elsevier B.V. All rights reserved.
    DOI:
    10.1016/j.jfluchem.2004.09.002
  • 作为产物:
    描述:
    氯甲酸乙酯 作用下, 以 为溶剂, 反应 0.67h, 以61.50 g的产率得到3-氯-4-氟苯基异硫氰酸酯
    参考文献:
    名称:
    Synthesis and Quantitative Structure−Activity Relationships of Fluorine-Containing 4,4-Dihydroxylmethyl-2-aryliminooxazo(thiazo)lidines as Trehalase Inhibitors
    摘要:
    Five fluorine-containing 4,4-dihydroxylmethyl-2-aryliminooxazolidines and five 4,4-dihydroxylmethyl-2-aryliminothiazolidines were synthesized and evaluated for their inhibitory activity against trehalase in vitro. All these compounds were very readily synthesized compared with the natural trehalase inhibitors. They had moderate inhibitory activity toward trehalase, and showed larvicidal activity and inhibition action to insect flight. The steric parameters and semiempirical quantum parameters of these compounds were acquired by using the molecular modeling method and the PM3-SCF-MO method, respectively. A quantitative structure-activity relationship between half-inhibitory concentrations toward trehalase and the above parameters was established.
    DOI:
    10.1021/jf010632k
点击查看最新优质反应信息

文献信息

  • Antimicrobial and Anti-biofilm Activity of Thiourea Derivatives Bearing 3-amino-1H-1,2,4-triazole Scaffold
    作者:Joanna Stefanska、Karolina Stepien、Anna Bielenica、Daniel Szulczyk、Barbara Miroslaw、Anna E Koziol、Giuseppina Sanna、Filippo Iuliano、Silvia Madeddu、Michal Jozwiak、Marta Struga
    DOI:10.2174/1573406412666151204003146
    日期:2016.6.23
    3-amino-1H-1,2,4-triazole with the commercial aliphatic and aromatic isothiocyanates. The aliphatic isothiocyanate was used as reagent leading to substitution on NH atom of 3-aminotriazole ring, whereas the triazole amino group was substituted when isothiocyanate group was bonded to the Csp2 hybridized atom, e.g. an aryl or C=O fragment. All compounds were evaluated in vitro for the antimicrobial activity
    通过使3-氨基-1H-1,2,4-三唑与市售的脂族和芳族异硫氰酸酯反应,制得了21种硫脲衍生物。脂族异硫氰酸酯用作导致3-氨基三唑环的NH原子上取代的试剂,而当异硫氰酸酯基团键合至Csp2杂化原子,例如芳基或C = O片段时,三唑氨基被取代。在体外评估所有化合物的抗微生物活性。衍生物1、2、4、8、9、10和12对革兰氏阳性球菌(金黄色葡萄球菌和表皮葡萄球菌)显示出最高的抑制作用。观察到的MIC值在4–32μg/ mL范围内。还测试了化合物对医院中耐金霉素的金黄色葡萄球菌菌株的体外抗菌活性。观察到的MIC值从4到64μg/ mL不等。产物4和10有效地抑制了耐甲氧西林和表皮葡萄球菌标准菌株的生物膜的形成。与对照相比,发现化合物10的IC50值为2–6μg/ mL更有希望。此外,评估了所有研究的硫脲对MT-4细胞的细胞毒性。化合物18具有明显的细胞毒性(CC50 = 8μM)。
  • Synthesis, cytotoxicity and antimicrobial activity of thiourea derivatives incorporating 3-(trifluoromethyl)phenyl moiety
    作者:Anna Bielenica、Joanna Stefańska、Karolina Stępień、Agnieszka Napiórkowska、Ewa Augustynowicz-Kopeć、Giuseppina Sanna、Silvia Madeddu、Stefano Boi、Gabriele Giliberti、Małgorzata Wrzosek、Marta Struga
    DOI:10.1016/j.ejmech.2015.06.027
    日期:2015.8
    A total of 31 of thiourea derivatives was prepared reacting 3-(trifluoromethyl)aniline and commercial aliphatic and aromatic isothiocyanates. The yields varied from 35% to 82%. All compounds were evaluated in vitro for antimicrobial activity. Derivatives 3, 5, 6, 9, 15, 24 and 27 showed the highest inhibition against Gram-positive cocci (standard and hospital strains). The observed MIC values were
    制备了总共31种使3-(三氟甲基)苯胺与市售脂族和芳族异硫氰酸酯反应的硫脲衍生物。产率从35%到82%不等。在体外评估所有化合物的抗微生物活性。衍生物3,5,6,9,15,24和27显示出对革兰氏阳性球菌(标准和医院的菌株)的最高抑制。观察到的MIC值在0.25–16μg/ ml的范围内。研究了硫脲5和15对从金黄色葡萄球菌分离的拓扑异构酶IV的抑制活性。产品5和15有效抑制了耐甲氧西林和表皮葡萄球菌的标准菌株的生物膜形成。此外,评估了所有获得的硫脲对大量DNA和RNA病毒的细胞毒性和抗病毒活性。化合物5,6,8-12,15导致细胞毒性对MT-4细胞(CC 50  ≤10μM)。
  • Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses
    作者:Vadim A. Makarov、Heike Braun、Martina Richter、Olga B. Riabova、Johannes Kirchmair、Elena S. Kazakova、Nora Seidel、Peter Wutzler、Michaela Schmidtke
    DOI:10.1002/cmdc.201500304
    日期:2015.10
    characterization of pyrazolopyrimidines, a well‐tolerated and potent class of novel EV inhibitors. The compounds inhibit the replication of a broad spectrum of EV in vitro with IC50 values between 0.04 and 0.64 μM for viruses resistant to pleconaril, a known capsid‐binding inhibitor, without affecting cytochrome P450 enzyme activity. Using virological and genetics methods, the viral capsid was identified
    当前尚无可用于治疗由肠病毒(EV)引起的急性和慢性疾病的药物,例如普通感冒,脑膜炎,脑炎,肺炎和心肌炎,伴或不伴连续性扩张性心肌病。在这里,我们报告吡唑并嘧啶的发现和表征,吡唑并嘧啶是一类耐受性强且有效的新型EV抑制剂。化合物抑制EV的体外广谱与IC的复制50值之间的0.04和0.64μ中号适用于对pleconaril(一种已知的衣壳结合抑制剂)有抗性的病毒,而不会影响细胞色素P450酶的活性。使用病毒学和遗传学方法,病毒衣壳被确定为最有希望的,口服生物利用的化合物3-(4-三氟甲基苯基)氨基-6-苯基吡唑并[3,4- d ]嘧啶-4-胺(OBR-5 )的靶标-340)。柯萨奇病毒B3引起的小鼠慢性心肌炎的预防性和治疗性应用都得到了证明。小鼠体内良好的药代动力学,毒理学和药效学特征使OBR-5340成为高度有前途的候选药物,并且正在进行非临床监管计划。
  • Fluorinated thiazolidinols cause cell death in A549 lung cancer cells via PI3K/AKT/mTOR and MAPK/ERK signalling pathways
    作者:Ravindra M. Kumbhare、Tulshiram L. Dadmal、Dinesh Kumar、M. Janaki Ramaiah、Anudeep Kota、Debabrata Chowdhury、K. Appalanaidu、Y. Khageswara Rao、Sayyad Hyder、T. Anjana Devi、Manika Pal Bhadra
    DOI:10.1039/c5md00603a
    日期:——

    Fluorinated thiazolidinols cause A549 lung cancer cell death by acting via PI3K/Akt/mTOR and MEK/ERK pathways.

    氟化噻唑醇通过PI3K/Akt/mTOR和MEK/ERK途径导致A549肺癌细胞死亡。
  • [EN] IMIDAZOL- OR 1,2,4-TRIAZOL-DERIVATIVES AND THEIR USE<br/>[FR] DÉRIVÉS D'IMIDAZOLE OU DE 1,2,4-TRIAZOL ET LEUR UTILISATION
    申请人:UNIV LILLE II DROIT & SANTE
    公开号:WO2015189330A1
    公开(公告)日:2015-12-17
    The present invention is directed to novel compounds of formula (I), pharmaceutically acceptable salts or solvates thereof, and their use.
    本发明涉及公式(I)的新化合物,其药学上可接受的盐或溶剂,以及它们的用途。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
mass
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐